Home > Riviste > Otorinolaringologia > Fascicoli precedenti > Otorinolaringologia 2014 June;64(2) > Otorinolaringologia 2014 June;64(2):33-8





Rivista di Otorinolaringologia, Chirurgia Maxillo-Facciale,
Chirurgia Plastica Ricostruttiva, Otoneurochirurgia

Indexed/Abstracted in: EMBASE, Scopus




Otorinolaringologia 2014 June;64(2):33-8

lingua: Inglese

Drug-eluting stents in sinus surgery

Campbell R. G. 1, Kennedy D. W. 2

1 Department of Otorhinolaryngology, Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA;
2 Rhinology Professor, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA


In the surgical management of chronic rhinosinusitis, medical therapy is often used to prevent postoperative complications such as adhesions. These complications often require unconfortable debridements in the clinic or revision surgery. Systemic steroids are not without risk and topical steroids are not ideal as duration of mucosal contact and exact dosage are unknown and penetration into gravity-dependent sinuses is suboptimal. Therefore, we reviewed the literature assessing the use of drug-eluting stents in the management of chronic rhinosinusitis. Three randomized controlled trials and a meta-analysis support the efficacy and safety of the use of steroid-eluting implants in chronic rhinosinusitis. Ethmoid sinus implants placed at the time of surgery have been found to significantly reduce postoperative adhesions, recurrence of polyposis, middle turbinate lateralization, the need for postoperative oral steroids and the need for postoperative interventions. Studies also support the ocular safety of steroid-eluting implants. Steroid-eluting implants are safe and an effective addition to the armamentarium utilized in the management of chronic rhinosinusitis. Future developments for the use of drug-eluting implants in chronic rhinosinusitis are discussed.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail